TABLE 2

Physiologic and compound-specific fixed model parameters associated with the disposition of AKP-001 and metabolites in rats

ParametersUnitValuesSources
Physiologic
Vhl/kg0.078Davies and Morris, 1993
Qhl/kg3.3Davies and Morris, 1993
Vlumenl/kg0.028aMcConnell et al., 2008
AKP-001
Kp,AKP1b
FAKP0.01c
M1
Kp,M11b
CLr,M1l/h/kg0.415d
FaFgM11b
M2
Kp,M21b
FaFgM2H0.923e
 Lag time1.5f
  • a The sum of small intestine and large intestine water content reported by McConnell et al., 2008.

  • b Liver-plasma concentration partition coefficients of AKP-001 and metabolites, and intestinal availability of M1 were assumed to be one.

  • c FAKP was calculated by dividing the dose-normalized AUC of AKP-001 after oral dosing to that after intravenous dosing.

  • d CLr,M1 was estimated by dividing the total amount of M1 excreted in urine by the AUC of M1 after oral administration of AKP-001.

  • e Intestinal availability of M2 was calculated by dividing the hepatic availability by the oral bioavailability (see Materials and Methods).

  • f Lag time for the formation of M2 in gut was considered on the basis of plasma M2 concentration-time profiles after oral administration of AKP-001.